SCHEMBL7984479

SCHEMBL7984479

CC(C)(C)OC(=O)Nc1ccc(-c2nc3ncn(Cc4ccccc4)c3c(=O)[nH]2)cc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.52
SMN1; SMN2 Q16637 4/20 0.49
ALDH1A1 P00352 2/20 0.49
KMT2A Q03164 1/20 0.44
P2RX7 Q99572 1/20 0.42
CYP17A1 P05093 2/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.40
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
PARN O95453 1/20 0.39
CNOT7 Q9UIV1 1/20 0.39
PRMT5 O14744 2/20 0.39
CDK9 P50750 1/20 0.38
SLC2A1 P11166 1/20 0.38
EGFR P00533 1/20 0.38
SRC P12931 1/20 0.38
MAPKAPK2 P49137 1/20 0.38
PSMB8 P28062 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984759 0.91 HPGD (0.49) HPGDSMN1; SMN2ALDH1A1KMT2AP2RX7
SCHEMBL7984489 0.86 P2RX7 (0.45) HPGDSMN1; SMN2ALDH1A1P2RX7CYP17A1
SCHEMBL7985473 0.83 HPGD (0.49) HPGDSMN1; SMN2ALDH1A1KMT2AKDM4E
SCHEMBL7974456 0.83 SMN1; SMN2 (0.55) HPGDSMN1; SMN2ALDH1A1KMT2APARN
SCHEMBL7984487 0.82 ADORA3 (0.43) HPGDSMN1; SMN2ALDH1A1P2RX7CYP17A1
SCHEMBL7975265 0.80 SMN1; SMN2 (0.61) HPGDSMN1; SMN2ALDH1A1KMT2APARN
SCHEMBL7991429 0.80 HPGD (0.55) HPGDSMN1; SMN2ALDH1A1KMT2AP2RX7
SCHEMBL7988556 0.80 SMN1; SMN2 (0.58) HPGDSMN1; SMN2ALDH1A1KMT2APARN
SCHEMBL7985230 0.79 ALDH1A1 (0.53) HPGDSMN1; SMN2ALDH1A1KMT2AKDM4E
SCHEMBL7984453 0.78 ALDH1A1 (0.56) HPGDSMN1; SMN2ALDH1A1KMT2APARN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed